This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $417.35 in the latest trading session, marking a +0.26% move from the prior day.
Why Should You Hold onto Anthem (ANTM) in Your Portfolio?
by Zacks Equity Research
Riding high on growing revenues, solid guidance and strategic initiatives, Anthem (ANTM) holds potential to reap benefits for investors.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $416.85, marking a -0.69% move from the previous day.
Cigna (CI) Expands Its Footprint in the ACA Marketplace
by Zacks Equity Research
Cigna (CI) expands its plan offerings on the Affordable Care Act's insurance exchanges, branching out into additional counties across three states for 2022.
UnitedHealth Group (UNH) Arm Wins Medicaid Contract in Nevada
by Zacks Equity Research
UnitedHealth Group's (UNH) Nevada unit aims to get better health outcomes of the state's Medicaid beneficiaries via its recent Medicaid program contract win in the counties of Clark and Washoe.
'Animal Spirits' Show There Feathers
by Daniel Laboe
An elevated level of new daily 52-week highs and lows exemplify a polarizing stock market with an equal mix of hope and fear
UnitedHealth Group (UNH) Boasts Earnings & Price Momentum: Should You Buy?
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $429.71 in the latest trading session, marking a +0.43% move from the prior day.
UnitedHealth (UNH) Hits 52-Week High: Hold it for Steady Growth
by Zacks Equity Research
UnitedHealth's (UNH) business diversification, presence in the niche markets and balance sheet strength make it a stock to be retained for long-term gains.
4 Health Insurance Companies Poised for Growth in 2H21
by Srijita Guha
Strategic initiatives, rising enrolment and strength in Medicaid business are expected to aid health insurance companies like CNC, ANTM, MOH and UNH in 2H21.
Here's Why You Should Retain UnitedHealth Group (UNH) Stock
by Zacks Equity Research
UnitedHealth Group (UNH) gains from improved revenues stemming from strong segmental performances, expansion of service offerings and a strong cash balance.
The Zacks Analyst Blog Highlights: Walmart, UnitedHealth, Starbucks, Lam Research and Sinopec
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walmart, UnitedHealth, Starbucks, Lam Research and Sinopec
Top Analyst Reports for Walmart, UnitedHealth & Starbucks
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), UnitedHealth Group Incorporated (UNH), and Starbucks Corporation (SBUX).
Clover Health (CLOV) Stock Rises on Impressive Q2 Revenues
by Zacks Equity Research
Share value of Clover Health (CLOV) hits through the roof on the back of a solid revenue and earnings outlook.
Why UnitedHealth Group (UNH) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MEDNAX's (MD) Earnings Beat Estimates in Q2, Improve Y/Y
by Zacks Equity Research
MEDNAX's (MD) Q2 results reflect solid volumes, partly offset by escalating expenses.
Cigna (CI) Q2 Earnings Beat on Revenue Growth But Shares Fall
by Zacks Equity Research
Cigna's (CI) better-than-expected Q2 earnings benefit from better revenues, partly offset by higher medical cost.
What's in Store for Cigna's (CI) Earnings in Q2?
by Zacks Equity Research
Cigna's (CI) Q2 results are likely to reflect an increase in revenues but a decline in its bottom line.
Ensign Group's (ENSG) Q2 Earnings In Line, Increase Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q2 results gain from higher revenues, cost management, and better census and managed care skilled mix across its portfolio.
Molina Healthcare (MOH) Misses on Q2 Earnings, Hikes '21 View
by Zacks Equity Research
Molina Healthcare's (MOH) Q2 earnings suffer escalating expenses. However, the same was partly offset by improved revenues and better membership.
Community Health (CYH) Q2 Earnings Beat, Hikes '21 EPS View
by Zacks Equity Research
Community Health's (CYH) second-quarter results indicate higher revenues and strong admission growth, partly offset by elevated expenses.
Humana's (HUM) Q2 Earnings Surpass Estimates, Tumble Y/Y
by Zacks Equity Research
Humana's (HUM) second-quarter earnings gain from higher revenues and strong performances by its Retail and Healthcare Services segments.
Centene's (CNC) Q2 Earnings Miss Estimates, Improve Y/Y
by Zacks Equity Research
Centene's (CNC) second-quarter earnings gain from better revenues and membership growth.
Universal Health (UHS) Beats on Q2 Earnings, Ups '21 EPS View
by Zacks Equity Research
Universal Health's (UHS) second-quarter results reflect growing revenues attributable to strong segmental performances, partly offset by elevated expenses.
Healthcare ETFs in Focus as Q2 Earnings Unfold
by Sweta Killa
The healthcare sector has been benefiting from COVID-19 vaccines or treatment with many more to come.